Iguratimod
Product Description
Chemox Pharma Pvt Ltd
-
Country/Region:India
-
On CPHI since:2025
-
Certificates:3
-
Employees:50 - 99
Company types
Primary activities
Categories
Specifications
Chemox Pharma Pvt Ltd
-
Country/Region:India
-
On CPHI since:2025
-
Certificates:3
-
Employees:50 - 99
Company types
Primary activities
More Products from Chemox Pharma Pvt Ltd (18)
-
Product Benfotiamine
Benfotiamine [CAS No: 22457-89-2], also known as S-benzoylthiamine O-monophosphate, is a highly bioavailable lipid-soluble derivative of Vitamin B1 (Thiamine). As an advanced thiamine analogue, Benfotiamine plays an essential role in maintaining healthy nerve cell metabolism and supporting normal cellular ... -
Product CITICOLINE SODIUM
Citicoline Sodium [Cas No: 33818-15-4], is also known as CDP- Choline Sodium Salt, which is a main intermediate in the synthesis of phosphatidylcholine. Citicoline Sodium also plays a key role in maintaining brain cell membrane integrity and supports neurotransmitter synthesis. The use of Citicoline Sodium... -
Product Deferoxamine Mesylate
Deferoxamine Mesylate is an iron-chelating agent used to treat acute iron poisoning and chronic iron overload disorders. It works by binding excess iron in the bloodstream and tissues to form a stable complex called ferrioxamine, which is eliminated from the body through urine and bile. The ... -
Product DORZOLAMIDE
Dorzolamide Hydrochloride [Cas No. 130693-82-2] is a carbonic anhydrase inhibitor API widely used for treatment of glaucoma and ocular hypertension. Dorzolamide Hydrochloride inhibits carbonic anhydrase in the ciliary body by which it reduces aqueous humor production and lowers intraocular pressure [IOP]. ... -
Product Ethyl 4-(2-hydroxy-2-propyl)-2-propyl-imidazole-5-carboxylate - OLMI-1
Chemox Pharma is a leading manufacturer and supplier of Ethyl 4-(2-hydroxy-2-propyl)-2-propyl-imidazole-5-carboxylate (CAS No.: 144689-93-0), also known as Olmesartan Intermediate – OLMI-1. This intermediate is a key raw material in the synthesis of Olmesartan Medoxomil, an angiotensin II receptor blocker ... -
Product FLUCONAZOLE
Fluconazole [Cas No. 86386-73-4] is a triazole antifungal API which is widely used for topical and systemic antifungal therapies. Fluconazole is first generation compound that targets a broad spectrum of fungus by inhibiting 14α-demethylase enzyme, which is a key component for ergosterol synthesis. Leading... -
Product Montelukast Sodium
Montelukast Sodium is an active pharmaceutical ingredient (API) widely recognized for its efficacy in the treatment and management of asthma and allergic rhinitis. Montelukast Sodium acts as a selective and competitive leukotriene receptor antagonist, inhibiting the cysteinyl leukotriene (CysLT1) receptor ... -
Product NITROFURANTOIN
Nitrofurantoin [Cas No. 67-20-9] is an antibacterial API which is effectively used for the treatment and prevention of urinary tract infections [UTIs]. Common market brand name for Nitrofurantoin is Macrobid, which breaks bacterial enzyme systems and DNA, resulting in inhibiting bacterial growth. Nitrofura... -
Product Relugolix
Relugolix is a nonpeptide, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist. It acts directly on GnRH receptors in the pituitary gland, reducing the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which subsequently decreases sex hormone production.
... -
Product Rosuvastatin Calcium
Rosuvastatin Calcium [CAS No: 147098-20-2] is used to manage dyslipidemia and prevent cardiovascular diseases. Rosuvastatin Calcium is widely used to reduce elevated levels of LDL cholesterol, total cholesterol and triglycerides, and moderately increase HDL cholesterol. Rosuvastatin Calcium is a HMG-CoA re... -
Product Silodosin
Silodosin is a selective alpha-1 adrenergic receptor antagonist primarily targeting the α1A receptor subtype. It is used to improve urinary symptoms associated with benign prostatic hyperplasia (BPH) by relaxing smooth muscle in the prostate and lower urinary tract.
Silodosin has a high affinity... -
Product Tadalafil
Tadalafil Citrate [Cas No. 171596-29-5] is a pharma grade phosphodiesterase type 5 [PDE5] inhibitor API which has potency in treating erectile dysfunction [ED] and pulmonary arterial hypertension [PAH]. Tadalafil Citrate has pyrazinopyridoindole and benzodioxol derivative that enhances nitric acid [NO] med...